A Phase II Clinical Trial of Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone (R-CyBor-D) in Relapsed Low Grade and Mantle Cell Lymphoma
暂无分享，去创建一个
T. Habermann | P. L. Bergsagel | A. Dueck | D. Northfelt | C. Reeder | T. Witzig | Daniel J. Johnson | R. Tiedemann | J. Leis | C. Nichols | J. Slack | A. Rosenthal | K. Gano | P. Johnston | Ángela Toro | S. K. N. Reddy